11/15/2024
8:54 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
4:00 PM | T2 Biosystems (Filer)
| Form PRE 14A | |
11/08/2024
8:30 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
8:01 PM | Safier Jacob (Filed by)
T2 Biosystems (Subject)
| Form SC 13G | |
11/06/2024
8:02 PM | JSAF Holdings, LLC (Filed by)
T2 Biosystems (Subject)
| Form SC 13G | |
10/16/2024
3:59 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
8:00 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
09/20/2024
7:59 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:00 PM | Elsbree David B (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
8:16 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
9:31 AM | Elsbree David B (Reporting)
T2 Biosystems (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
8:10 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:31 PM | T2 Biosystems (Filer)
| Form 424B5 | |
08/15/2024
7:26 PM | New Dimensions Trading (Filed by)
T2 Biosystems (Subject)
| Form SC 13G/A | |
08/15/2024
7:24 PM | Safier Jacob (Filed by)
T2 Biosystems (Subject)
| Form SC 13G/A | |
08/08/2024
3:49 PM | T2 Biosystems (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
11:15 PM | T2 Biosystems (Filer)
| Form EFFECT | |
07/29/2024
4:00 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:04 PM | T2 Biosystems (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/19/2024
3:16 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
11:15 PM | T2 Biosystems (Filer)
| Form EFFECT | |
05/24/2024
8:04 PM | T2 Biosystems (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/22/2024
3:49 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
6:00 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:55 PM | T2 Biosystems (Filer)
| Form RW | |
05/14/2024
3:43 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:21 PM | CR Group L.P. (Filed by)
T2 Biosystems (Subject)
| Form SC 13D/A | |
05/13/2024
5:19 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:29 PM | T2 Biosystems (Subject)
| Form FWP | |
05/07/2024
6:46 PM | CR Group L.P. (Filed by)
T2 Biosystems (Subject)
| Form SC 13D/A | |
05/07/2024
3:57 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
8:38 PM | T2 Biosystems (Subject)
| Form FWP | |
05/06/2024
8:40 PM | T2 Biosystems (Subject)
| Form FWP | |
05/06/2024
4:19 PM | T2 Biosystems (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
4:24 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
4:27 PM | T2 Biosystems (Filer)
| Form S-1/A | |
05/06/2024
6:48 AM | T2 Biosystems (Filer)
| Form S-1/A | |
04/22/2024
4:13 PM | T2 Biosystems (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/19/2024
3:31 PM | CR Group L.P. (Filed by)
T2 Biosystems (Subject)
| Form SC 13D | |
04/16/2024
7:35 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:47 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This company will win the AI race (Ad) Rome wasn’t built in a day…
But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence.
And without it, the entire AI industry would collapse.  You must read this new presentation from Porter Stansberry. |
03/28/2024
3:31 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
8:17 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
8:06 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
8:00 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
5:11 PM | New Dimensions Trading (Filed by)
T2 Biosystems (Subject)
| Form SC 13G | |
03/11/2024
5:14 PM | Safier Jacob (Filed by)
T2 Biosystems (Subject)
| Form SC 13G | |
03/04/2024
3:34 PM | T2 Biosystems (Filer)
| Form DEF 14A | |
02/16/2024
4:17 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:47 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
3:49 PM | T2 Biosystems (Filer)
| Form PRE 14A | |
02/13/2024
7:15 PM | Lind Global Fund II LP (Filed by)
T2 Biosystems (Subject)
| Form SC 13G/A | |
11/28/2023
3:00 PM | Giffin Brett A. (Reporting)
T2 Biosystems (Issuer)
| Form 4/A | |
11/24/2023
3:30 PM | T2 Biosystems (Filer)
| Form 8-K/A | |
